Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable advanced therapies and vaccine production, has completed €2 million expansion of its Nivelles, Belgium site. The investment aims to deliver greater support and supply chain security to biomanufacturers.   Nivelles site expansion began in December 2020 when the company doubled its overall footprint. The initial focus was on expanding warehouse storage as well as the ISO 8 clean room space, grea...